Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection

Overview of attention for article published in Frontiers in immunology, April 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 740 followers.

Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection https://t.co/PusDymREGM

En resumen, estos mutantes ACE2 representan un enfoque novedoso para prevenir o tratar el COVID-19 y otros virus con la misma proteína de pico. #longcovid #covidpersistente https://t.co/F8sfNiadhl

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.